 | • レポートコード：B-GIR09D2367 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ナノ医薬品の世界市場について調べ、まとめました。種類別セグメントは、リポソーム、ポリマー、ナノクリスタル、タンパク質、その他等、用途別セグメントは、腫瘍学、神経学、免疫学、抗感染症、心血管、その他等に区分しました。ナノ医薬品の世界市場概観、メーカー動向、メーカー別ナノ医薬品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ナノ医薬品の市場概観 ・ナノ医薬品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ナノ医薬品の企業別販売動向、市場シェア、市場集中度、競争動向 ・ナノ医薬品の世界市場規模 ・ナノ医薬品の北米市場分析（アメリカ、カナダ、メキシコ等） ・ナノ医薬品のアメリカ市場規模推移 ・ナノ医薬品のカナダ市場規模推移 ・ナノ医薬品のメキシコ市場規模推移 ・ナノ医薬品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ナノ医薬品のドイツ市場規模推移 ・ナノ医薬品のイギリス市場規模推移 ・ナノ医薬品のロシア市場規模推移 ・ナノ医薬品のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ナノ医薬品の日本市場規模推移 ・ナノ医薬品の中国市場規模推移 ・ナノ医薬品の韓国市場規模推移 ・ナノ医薬品のインド市場規模推移 ・ナノ医薬品の東南アジア市場規模推移 ・ナノ医薬品の南米市場分析（ブラジル、アルゼンチン等） ・ナノ医薬品の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ナノ医薬品の種類別分析/販売量、売上、市場シェア（リポソーム、ポリマー、ナノクリスタル、タンパク質、その他） ・ナノ医薬品の用途別分析/市場規模（腫瘍学、神経学、免疫学、抗感染症、心血管、その他） ・ナノ医薬品の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ナノ医薬品の販売チャネル・代理店・貿易業者・ディーラー分析 |
The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.
Scope of the Report:
The worldwide market for Nanopharmaceutical Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nanopharmaceutical Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
Merck
AstraZeneca
Gilead Sciences
Abbvie
Amgen
Roche
Novartis
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liposomes
Polymer
Nanocrystals
Protein
Others
Market Segment by Applications, can be divided into
Oncology
Neurology
Immunology
Anti-Infective
Cardiovascular
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nanopharmaceutical Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nanopharmaceutical Drugs, with price, sales, revenue and global market share of Nanopharmaceutical Drugs in 2017 and 2018.
Chapter 3, the Nanopharmaceutical Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nanopharmaceutical Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nanopharmaceutical Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nanopharmaceutical Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nanopharmaceutical Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Liposomes
1.2.2 Polymer
1.2.3 Nanocrystals
1.2.4 Protein
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Neurology
1.3.3 Immunology
1.3.4 Anti-Infective
1.3.5 Cardiovascular
1.3.6 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Nanopharmaceutical Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Nanopharmaceutical Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Nanopharmaceutical Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Gilead Sciences
2.4.1 Business Overview
2.4.2 Nanopharmaceutical Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Gilead Sciences Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbvie
2.5.1 Business Overview
2.5.2 Nanopharmaceutical Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbvie Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Amgen
2.6.1 Business Overview
2.6.2 Nanopharmaceutical Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Roche
2.7.1 Business Overview
2.7.2 Nanopharmaceutical Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Nanopharmaceutical Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Nanopharmaceutical Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Nanopharmaceutical Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Nanopharmaceutical Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Nanopharmaceutical Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Nanopharmaceutical Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Nanopharmaceutical Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Nanopharmaceutical Drugs Market Analysis by Regions
4.1 Global Nanopharmaceutical Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Nanopharmaceutical Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Nanopharmaceutical Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
4.5 South America Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
5 North America Nanopharmaceutical Drugs by Country
5.1 North America Nanopharmaceutical Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Nanopharmaceutical Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Nanopharmaceutical Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
6 Europe Nanopharmaceutical Drugs by Country
6.1 Europe Nanopharmaceutical Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Nanopharmaceutical Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Nanopharmaceutical Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
6.3 UK Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
6.4 France Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Nanopharmaceutical Drugs by Country
7.1 Asia-Pacific Nanopharmaceutical Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Nanopharmaceutical Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Nanopharmaceutical Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
7.5 India Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
8 South America Nanopharmaceutical Drugs by Country
8.1 South America Nanopharmaceutical Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Nanopharmaceutical Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Nanopharmaceutical Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Nanopharmaceutical Drugs by Countries
9.1 Middle East and Africa Nanopharmaceutical Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Nanopharmaceutical Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Nanopharmaceutical Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
10 Global Nanopharmaceutical Drugs Market Segment by Type
10.1 Global Nanopharmaceutical Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Nanopharmaceutical Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Nanopharmaceutical Drugs Revenue and Market Share by Type (2014-2019)
10.2 Liposomes Sales Growth and Price
10.2.1 Global Liposomes Sales Growth (2014-2019)
10.2.2 Global Liposomes Price (2014-2019)
10.3 Polymer Sales Growth and Price
10.3.1 Global Polymer Sales Growth (2014-2019)
10.3.2 Global Polymer Price (2014-2019)
10.4 Nanocrystals Sales Growth and Price
10.4.1 Global Nanocrystals Sales Growth (2014-2019)
10.4.2 Global Nanocrystals Price (2014-2019)
10.5 Protein Sales Growth and Price
10.5.1 Global Protein Sales Growth (2014-2019)
10.5.2 Global Protein Price (2014-2019)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2014-2019)
10.6.2 Global Others Price (2014-2019)
11 Global Nanopharmaceutical Drugs Market Segment by Application
11.1 Global Nanopharmaceutical Drugs Sales Market Share by Application (2014-2019)
11.2 Oncology Sales Growth (2014-2019)
11.3 Neurology Sales Growth (2014-2019)
11.4 Immunology Sales Growth (2014-2019)
11.5 Anti-Infective Sales Growth (2014-2019)
11.6 Cardiovascular Sales Growth (2014-2019)
11.7 Others Sales Growth (2014-2019)
12 Nanopharmaceutical Drugs Market Forecast (2019-2024)
12.1 Global Nanopharmaceutical Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Nanopharmaceutical Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Nanopharmaceutical Drugs Market Forecast (2019-2024)
12.2.2 Europe Nanopharmaceutical Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Nanopharmaceutical Drugs Market Forecast (2019-2024)
12.2.4 South America Nanopharmaceutical Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Nanopharmaceutical Drugs Market Forecast (2019-2024)
12.3 Nanopharmaceutical Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Nanopharmaceutical Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Nanopharmaceutical Drugs Market Share Forecast by Type (2019-2024)
12.4 Nanopharmaceutical Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Nanopharmaceutical Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Nanopharmaceutical Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Nanopharmaceutical Drugs Picture
Table Product Specifications of Nanopharmaceutical Drugs
Figure Global Sales Market Share of Nanopharmaceutical Drugs by Types in 2018
Table Nanopharmaceutical Drugs Types for Major Manufacturers
Figure Liposomes Picture
Figure Polymer Picture
Figure Nanocrystals Picture
Figure Protein Picture
Figure Others Picture
Figure Nanopharmaceutical Drugs Sales Market Share by Applications in 2018
Figure Oncology Picture
Figure Neurology Picture
Figure Immunology Picture
Figure Anti-Infective Picture
Figure Cardiovascular Picture
Figure Others Picture
Figure United States Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Nanopharmaceutical Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Nanopharmaceutical Drugs Type and Applications
Table Pfizer Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Nanopharmaceutical Drugs Type and Applications
Table Merck Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Nanopharmaceutical Drugs Type and Applications
Table AstraZeneca Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Nanopharmaceutical Drugs Type and Applications
Table Gilead Sciences Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Nanopharmaceutical Drugs Type and Applications
Table Abbvie Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Nanopharmaceutical Drugs Type and Applications
Table Amgen Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Nanopharmaceutical Drugs Type and Applications
Table Roche Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Nanopharmaceutical Drugs Type and Applications
Table Novartis Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Nanopharmaceutical Drugs Type and Applications
Table Sanofi Nanopharmaceutical Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Nanopharmaceutical Drugs Sales by Manufacturer (2017-2018)
Figure Global Nanopharmaceutical Drugs Sales Market Share by Manufacturer in 2017
Figure Global Nanopharmaceutical Drugs Sales Market Share by Manufacturer in 2018
Table Global Nanopharmaceutical Drugs Revenue by Manufacturer (2017-2018)
Figure Global Nanopharmaceutical Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Nanopharmaceutical Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Nanopharmaceutical Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Nanopharmaceutical Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Global Nanopharmaceutical Drugs Revenue and Growth Rate (2014-2019)
Table Global Nanopharmaceutical Drugs Sales by Regions (2014-2019)
Table Global Nanopharmaceutical Drugs Sales Market Share by Regions (2014-2019)
Table Global Nanopharmaceutical Drugs Revenue by Regions (2014-2019)
Figure Global Nanopharmaceutical Drugs Revenue Market Share by Regions in 2014
Figure Global Nanopharmaceutical Drugs Revenue Market Share by Regions in 2018
Figure North America Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Europe Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure South America Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure North America Nanopharmaceutical Drugs Revenue and Growth Rate (2014-2019)
Table North America Nanopharmaceutical Drugs Sales by Countries (2014-2019)
Table North America Nanopharmaceutical Drugs Sales Market Share by Countries (2014-2019)
Figure North America Nanopharmaceutical Drugs Sales Market Share by Countries in 2014
Figure North America Nanopharmaceutical Drugs Sales Market Share by Countries in 2018
Table North America Nanopharmaceutical Drugs Revenue by Countries (2014-2019)
Table North America Nanopharmaceutical Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Nanopharmaceutical Drugs Revenue Market Share by Countries in 2014
Figure North America Nanopharmaceutical Drugs Revenue Market Share by Countries in 2018
Figure United States Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Canada Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Europe Nanopharmaceutical Drugs Revenue and Growth Rate (2014-2019)
Table Europe Nanopharmaceutical Drugs Sales by Countries (2014-2019)
Table Europe Nanopharmaceutical Drugs Sales Market Share by Countries (2014-2019)
Table Europe Nanopharmaceutical Drugs Revenue by Countries (2014-2019)
Figure Europe Nanopharmaceutical Drugs Revenue Market Share by Countries in 2017
Figure Europe Nanopharmaceutical Drugs Revenue Market Share by Countries in 2018
Figure Germany Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure UK Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure France Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Russia Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Italy Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Nanopharmaceutical Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Nanopharmaceutical Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Nanopharmaceutical Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Nanopharmaceutical Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Nanopharmaceutical Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Nanopharmaceutical Drugs Revenue Market Share by Countries 2018
Figure China Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Japan Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Korea Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure India Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure South America Nanopharmaceutical Drugs Revenue and Growth Rate (2014-2019)
Table South America Nanopharmaceutical Drugs Sales by Countries (2014-2019)
Table South America Nanopharmaceutical Drugs Sales Market Share by Countries (2014-2019)
Figure South America Nanopharmaceutical Drugs Sales Market Share by Countries in 2018
Table South America Nanopharmaceutical Drugs Revenue by Countries (2014-2019)
Table South America Nanopharmaceutical Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Nanopharmaceutical Drugs Revenue Market Share by Countries in 2018
Figure Brazil Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Nanopharmaceutical Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Nanopharmaceutical Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Nanopharmaceutical Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Nanopharmaceutical Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Nanopharmaceutical Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Nanopharmaceutical Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nanopharmaceutical Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Nanopharmaceutical Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure UAE Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Nanopharmaceutical Drugs Sales and Growth Rate (2014-2019)
Table Global Nanopharmaceutical Drugs Sales by Type (2014-2019)
Table Global Nanopharmaceutical Drugs Sales Share by Type (2014-2019)
Table Global Nanopharmaceutical Drugs Revenue by Type (2014-2019)
Table Global Nanopharmaceutical Drugs Revenue Share by Type (2014-2019)
Figure Global Liposomes Sales Growth (2014-2019)
Figure Global Liposomes Price (2014-2019)
Figure Global Polymer Sales Growth (2014-2019)
Figure Global Polymer Price (2014-2019)
Figure Global Nanocrystals Sales Growth (2014-2019)
Figure Global Nanocrystals Price (2014-2019)
Figure Global Protein Sales Growth (2014-2019)
Figure Global Protein Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Nanopharmaceutical Drugs Sales by Application (2014-2019)
Table Global Nanopharmaceutical Drugs Sales Share by Application (2014-2019)
Figure Global Neurology Sales Growth (2014-2019)
Figure Global Immunology Sales Growth (2014-2019)
Figure Global Anti-Infective Sales Growth (2014-2019)
Figure Global Cardiovascular Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Nanopharmaceutical Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Nanopharmaceutical Drugs Sales Forecast by Regions (2019-2024)
Table Global Nanopharmaceutical Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Nanopharmaceutical Drugs Market Forecast (2019-2024)
Figure Europe Sales Nanopharmaceutical Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Nanopharmaceutical Drugs Market Forecast (2019-2024)
Figure South America Sales Nanopharmaceutical Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Nanopharmaceutical Drugs Market Forecast (2019-2024)
Table Global Nanopharmaceutical Drugs Sales Forecast by Type (2019-2024)
Table Global Nanopharmaceutical Drugs Market Share Forecast by Type (2019-2024)
Table Global Nanopharmaceutical Drugs Sales Forecast by Application (2019-2024)
Table Global Nanopharmaceutical Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の腫瘍ジェネリック注射薬市場予測（～2024年） Generic drugs are essential in oncology because some anticancer drugs are only available as generics. Scope of the Report: The worldwide market for Oncology Generic Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx mill…- 世界の腫瘍薬市場予測（～2024年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Scope of the Report: Oncology Drugs is widely used For Blood Cancer, Bre…
- 抗感染性眼科市場：世界及び中国市場分析・予測（～2024年） Anti-infective Ophthalmic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Anti-infective Ophthalmic industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anti-infective Oph…
- 世界の免疫腫瘍アッセイキット市場予測（～2024年） Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoin…
- 世界の防食剤市場予測（～2024年） Anti corrosion agents are chemical substances or compounds that, when present in the environment (medium) in the appropriate concentration and form, can prevent or slow down corrosion of materials. Scope of the Report: The worldwide market for Anti Corrosion Agents is expected to grow at a CAGR of r…